期刊文献+

异质性万古霉素中介金黄色葡萄球菌的分离及检测方法的建立 被引量:2

Construction of new methods for the isolation and detection of heterogeneous vancomycin intermediate Stapylococus aureus
暂未订购
导出
摘要 目的了解异质性万古霉素中介金黄色葡萄球菌(h-VISA)的分离情况,并筛选简便可行的h-VISA的检测方法。方法采用琼脂稀释法和E-test法对分离出的113株金黄色葡萄球菌进行检测,筛选出的可疑h-VISA用菌谱分析法进行确认,并对文献推荐的几种方法的筛选效果进行比较。结果检测到1株万古霉素的MIC为3μg/mL和2株MIC为4μg/mL的MR-SA,为万古霉素敏感性减低的金黄色葡萄球菌,其中1株MIC为4μg/mL的MRSA经菌谱分析法证实为h-VISA,本次113株实验菌株h-VISA的检出率为0.88%。结论通过实验证实K-B法并不是检测h-VISA的理想方法,而菌谱分析法则较为有效,分离率为8.3%,且在本实验中灵敏度可达10-8。本院分离的MRSA中已出现万古霉素敏感性减低菌株,并分离出1株h-VISA,可见,MRSA对万古霉素的异质性中介耐药不容忽视,应引起国内医学界的广泛重视。 Objective To investigate the prevalence of heterogeneous vancomycin intermediate Stapylococus aureus(h-VISA) and develop a new method for the detection of h-VISA.Methods 113 strains of Staphylococcus aureus(SA) were screened by agar dilution method and E-test method.The resistant strains were confirmed by population analysis.Results Three strains of SA were with reduced susceptibility to vancomycin,including one strain with minimal inhibitory concentration(MIC) for 3 μg/mL and two strains with MIC for 4 μg/mL.One strain with MIC for 4 μg/mL was confirmed as h-VISA,and the detection rate was 0.88%(1/113).Conclusion Population analysis could be more effective than disc agar diffusion method,and the former might be with high sensitivity to 10-8.More attention should be paid to the emerge of strains with reduced susceptibility to vancomycin and h-VISA.
出处 《国际检验医学杂志》 CAS 2012年第13期1551-1553,共3页 International Journal of Laboratory Medicine
基金 甘肃省科技支撑计划项目(1011FKCA086)
关键词 葡萄球菌 金黄色 万古霉素 异质性耐药 菌谱分析法 Stapylococcus aureus; vancomycin; hetero-resistance; population analysis;
  • 相关文献

参考文献12

  • 1Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japa- nese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin[J]. Lancet, 1997,350(12) : 1670-1673.
  • 2Bobin Dubreux S, Reverdy ME, Nervi C, et al. Clinical isolate of vancomycin-hererointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant de- rivative[J]. Antimicrob Agents Chemother, 2001,45 ( 1 ): 349-352.
  • 3吴本权,唐英春,张扣兴,张天托,朱家馨,席云.万古霉素异质性耐药葡萄球菌的分离及其药物敏感性分析[J].中国抗生素杂志,2002,27(2):116-120. 被引量:31
  • 4王敬华,马筱玲,濮跃晨,陈多炎,鲁怀伟.Hetero-VRS检测方法的建立及其临床意义[J].现代检验医学杂志,2003,18(5):3-6. 被引量:9
  • 5Fridkin SK. Vancomycim intermediate and-resistant Staphylococ- cus aureus: what the infectious disease specialist needs to know[J]. Clin Inf Dis,2001,32(1) :108-115.
  • 6Tallent SM, Bischoff T,Climo M, et al. Vancomycin susceptibility of Oxacillim resistant Staphylococcus aureus isolates causing nos- ocomial bloodstream infections[J]. Clin Microbiol, 2002,40 (6) : 2249-2250.
  • 7Hiramatsu K, Kondo N, Ito T. Genetic basis for molecular epide- miology of methicillin-resistant staphylococcus aureus[J]. Infect Chemother, 1996,52(2) : 117-129.
  • 8Hsueh PR, Lee SY, Perng CL, et al. Clonal dissemination of meti- cillin-resistant and vaneomycin-intermediate Staphylococcus au- reus in a Taiwan Residents hospital[J]. Antimierob Agents,2010,36(4) : 307-312.
  • 9代洪,范学工.金黄色葡萄球菌万古霉素耐药与凝固酶活性[J].临床检验杂志,2006,24(1):19-22. 被引量:5
  • 10张涛,马筱玲,戴媛媛,鲁怀伟,陈多炎.万古霉素耐药金黄色葡萄球菌生物学特性[J].中国微生态学杂志,2007,19(1):50-53. 被引量:4

二级参考文献44

  • 1马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 2马筱玲.万古霉素敏感性减低的金黄色葡萄球菌[J].中华检验医学杂志,2004,27(9):620-622. 被引量:18
  • 3康格非,巫向前.临床生物化学和生物化学检验.北京:人民卫生出版社,1999.106.
  • 4[2]Fridkin S K.Vancomycin intermediate and-resistant Staphylococcus aureus:what the infectious disease specialist needs to know[J].Clin Infect Dis,2001,32 (1):108-115.
  • 5[3]Sieradzki K,Tomasz A.Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus[J].J Bacteriol,1997,179 (8):2557-2566.
  • 6[4]Moreira B,Boyle-Vavra S,Dejonge B L M,et al.Increased production of penicillin-binding protein 2,increased detection of other penicillinbinding proteins,and decreased coagulase activity associated with glycopeptid resistance in Staphylococcus aureus[J].Antimicrob Agents Chemother,1997,41 (8):1788-1793.
  • 7[5]Akineden O,AnnemOller C,Hassan A A,et al.Toxin genes and other characteristics of Staphylococcus aureus isolates from milk of cows with mastitis[J].Clin Diagn Lab Immunol,2001,8 (5):959-964.
  • 8[6]Schuermans A H,Peetermans W E,Struelens M J,et al.Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms[J].J Clin Microbiol,1997,35(10):2514-2520.
  • 9[7]van Belkum A,Bax R,Peerbooms P,et al.Comparison of phage typing and DNA fingerprinting by polymerase chain reaction for discrimination of methicillin-resistant Staphylococcus aureus strains[J].J Clin Microbiol.1993,31 (4):798-803.
  • 10[8]Goerke C,Campana S,Bayer M G,et al.Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro[J].Infection and Immunity,2000,68 (3):1304-1311.

共引文献44

同被引文献13

  • 1美国临床和实验室标准协会.抗菌药物敏感性试验执行标准CLSI M100-S22[S].中华检验医学杂志,2012,29(增刊):70-78.
  • 2美国临床和实验室标准协会.需氧菌的稀释法抗菌药物敏感性试验CLSI M07-A9[S].中华检验医学杂志,2012,29(增刊):27-28.
  • 3Jevons M P. Celbenin-resistant staphylococci[ J]. B MedJ, 1961,242:124-125.
  • 4Hiramatsu K, Cui L, Kuroda M, et al. The emergenceand evolution of methicillin-resistant Staphylococcus au-reus [ J]. Trends Microbiol, 2001,9( 10) :486-493.
  • 5Dumitrescu 0,Dauwalder 0,Boisset S,et al. Staphylo-coccus aureus resistance to antibiotics : key points in 2010[J]. Med Sci, 2011,26(11) :943-949.
  • 6Van Hal S J, Wehrhahn M C, Barbagiannakos T, et al.Performance of various testing methodologies for detectionof heteroresistant vancomycin-intermediate Staphylococcusaureus in bloodstream isolates [ J]. J Clin Microbiol,2011,49(4) :1489-1494.
  • 7Han J H, Edelstein P H , Lautenbach E. Reduced vanco-mycin susceptibility and staphylococcal cassette chromo-some mec ( SCCmec) type distribution in methicillin-re-sistant Staphylococcus aureus bacteraemia [ J]. J Antimi-crob Chemother,2012,67( 10) :2346-2349.
  • 8Pitz A M , Yu F,Hermsen E D,W al. Vancomycin sus-ceptibility trends and prevalence of heterogeneous vanco-mycin-intermediate Staphylococcus aureus in clinical me-thiciliin-resistant S. aureus isolates[ J] . J Clin Microbiol,2011,49(1) :269-274.
  • 9美国临床和实验室标准协会.抗菌药物敏感性试验执行标准CLSI M02-A11[S].中华检验医学杂志,2012,29(增刊):19.
  • 10Howden B P, Davies J K, Johnson P D, et al. Reducedvancomycin susceptibility in Staphylococcus aureus, in-cluding vancomycin-intermediate and heterogeneous van-comycin-intermediate strains : resistance mechanisms,la-boratory detection, and clinical implications [ J]. Clin Mi-crobiol Rev, 2010,23(1):99-139.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部